Jane Street’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Jane Street’s Portfolio ATXI Stock Details ATXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-399	Closed	-$4.42K	–	10376
2024 Q1	$4.42K	Buy	+399	New	+$4.73K	﹤0.01%	9020
2021 Q3	–	Sell	-12	Closed	-$34K	–	10909
2021 Q2	$34K	Buy	+12	New	+$59.2K	﹤0.01%	9573
2021 Q1	–	Sell	-12	Closed	-$79K	–	9686
2020 Q4	$79K	Buy	+12	New	+$62.9K	﹤0.01%	7254
2020 Q3	–	Sell	-12	Closed	-$151K	–	8087
2020 Q2	$151K	Buy	+12	New	+$135K	﹤0.01%	6551

Other funds holding ATXI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Jane Street's ATXI Position: Q2 2024 in Review

Jane Street sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q2 2024, closing a stake of 399 shares — an estimated $4.42K sold.

Jane Street first reported a position in ATXI in Q2 2020 and held it in 4 quarters. The position peaked at $151K in Q2 2020. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

Jane Street reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jane Street sold 399 Avenue Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.42K.
Jane Street first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Jane Street's Avenue Therapeutics, Inc. Common Stock position peaked at $151K in Q2 2020.
9 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.